A monoclonal antibody-β-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer
- 1 September 1992
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 66 (3), 474-478
- https://doi.org/10.1038/bjc.1992.298
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Analysis of a conjugate between anti-carcinoembryonic antigen monoclonal antibody and alkaline phosphatase for specific activation of the prodrug etoposide phosphateCancer Immunology, Immunotherapy, 1992
- Activation of methotrexate-.alpha.-alanine by carboxypeptidase A monoclonal antibody conjugateBiochemistry, 1992
- Anti-neoplastic glucuronide prodrug treatment of human tumor cells targeted with a monoclonal antibody-enzyme conjugateBiochemical Pharmacology, 1991
- The effects of γ-interferon combined with 5-fluorouracil or 5-fluoro-2′-deoxyuridine on proliferation and antigen expression in a panel of human colorectal cancer cell linesInternational Journal of Cancer, 1991
- Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamideCancer Immunology, Immunotherapy, 1990
- Acid pH in tumors and its potential for therapeutic exploitation.1989
- Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate.Proceedings of the National Academy of Sciences of the United States of America, 1988
- Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.1986
- Characterization of a xenograft model of human ovarian carcinoma which produces ascites and intraabdominal carcinomatosis in mice.1984
- Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excessJournal of Immunological Methods, 1984